Scintipharma, Inc.(Scintipharma) is a privately held company that is engaged in the development of pharmaceutical dosage. The company provide services to the pharmaceutical industry for the optimization of drug delivery systems. The Gamma scintigraphy is a technique uses by the company to transit of a dosage form through its intended site of delivery correlated with drug absorption. Scintipharma offers human clinical or animal studies, site specific delivery in the GI tract using the InteliSite capsule, regulatory compliance and expert consultation. The InteliSite capsule is a radiofrequency activated, non-disintegrating drug delivery device. Scintipharma is headquartered at Lexington in Kentucky, the US.